Michael Barbella, Managing Editor01.03.24
EndoSound Inc. and AdaptivEndo have signed a letter of intent to expand EndoSound's novel ultrasound technology into the single-use endoscopy space, thus improving patient safety and increasing access to care.
The collaboration between EndoSound and AdaptivEndo reached a significant milestone last year with the successful completion of an in-vivo porcine animal lab. During this trial, the teams demonstrated their ability to perform EUS with a single-use AdaptivEndo gastroscope and an AdaptivEndo duodenoscope. This achievement marked a historic moment as the first-ever simultaneous EUS/ERCP procedure using a singular EUS/ERCP device.
"The successful in-vivo lab represents a significant leap forward in the field of endoscopy," EndoSound CEO Dr. Steve Steinberg said. "We are thrilled to partner with AdaptivEndo. Together, we envision a future where healthcare professionals can perform EUS procedures confidently and conveniently with single-use equipment, further expanding patient access and ultimately improving outcomes."
EUS is a vital diagnostic and therapeutic tool in gastroenterology. Traditionally, EUS procedures have been performed with reusable endoscopes, which presents challenges related to infection control, sterilization, and access to care. Part of EndoSound’s mission is to make EUS safer and more accessible as exemplified in its elimination of difficult to clean moving parts (elevator) and delivering a product at a fraction of current costs. By integrating EndoSound's ultrasound technology into single-use endoscopes, this collaboration aims to bring these efforts further and offer an even safer and more accessible solution for patients and healthcare providers.
"Our collaboration with EndoSound signifies our commitment to pushing the boundaries of endoscopic technology. By combining our expertise in single-use endoscopy with EndoSound's revolutionary ultrasound technology, we aim to accelerate the time to market for both of our cutting-edge technologies," AdaptivEndo President Ed Fancher stated. "This partnership will reshape the endoscopy landscape, making advanced procedures more accessible and safer for patients."
This collaboration could potentially transform endoscopy, addressing key challenges and bringing state-of-the-art technologies to healthcare facilities worldwide.
EndoSound Inc. is a privately held company based in Portland, Ore., that is dedicated to expanding access to endoscopic ultrasound technology worldwide. With its patented design, EndoSound transforms an upper endoscope into a fully functional EUS scope.
AdaptivEndo is a pioneer in single-use endoscopy solutions, offering products designed to improve patient safety and streamline medical procedures. The company aims to make advanced endoscopic technology accessible to healthcare professionals worldwide, with a focus on enhancing patient outcomes and infection control.
The collaboration between EndoSound and AdaptivEndo reached a significant milestone last year with the successful completion of an in-vivo porcine animal lab. During this trial, the teams demonstrated their ability to perform EUS with a single-use AdaptivEndo gastroscope and an AdaptivEndo duodenoscope. This achievement marked a historic moment as the first-ever simultaneous EUS/ERCP procedure using a singular EUS/ERCP device.
"The successful in-vivo lab represents a significant leap forward in the field of endoscopy," EndoSound CEO Dr. Steve Steinberg said. "We are thrilled to partner with AdaptivEndo. Together, we envision a future where healthcare professionals can perform EUS procedures confidently and conveniently with single-use equipment, further expanding patient access and ultimately improving outcomes."
EUS is a vital diagnostic and therapeutic tool in gastroenterology. Traditionally, EUS procedures have been performed with reusable endoscopes, which presents challenges related to infection control, sterilization, and access to care. Part of EndoSound’s mission is to make EUS safer and more accessible as exemplified in its elimination of difficult to clean moving parts (elevator) and delivering a product at a fraction of current costs. By integrating EndoSound's ultrasound technology into single-use endoscopes, this collaboration aims to bring these efforts further and offer an even safer and more accessible solution for patients and healthcare providers.
"Our collaboration with EndoSound signifies our commitment to pushing the boundaries of endoscopic technology. By combining our expertise in single-use endoscopy with EndoSound's revolutionary ultrasound technology, we aim to accelerate the time to market for both of our cutting-edge technologies," AdaptivEndo President Ed Fancher stated. "This partnership will reshape the endoscopy landscape, making advanced procedures more accessible and safer for patients."
This collaboration could potentially transform endoscopy, addressing key challenges and bringing state-of-the-art technologies to healthcare facilities worldwide.
EndoSound Inc. is a privately held company based in Portland, Ore., that is dedicated to expanding access to endoscopic ultrasound technology worldwide. With its patented design, EndoSound transforms an upper endoscope into a fully functional EUS scope.
AdaptivEndo is a pioneer in single-use endoscopy solutions, offering products designed to improve patient safety and streamline medical procedures. The company aims to make advanced endoscopic technology accessible to healthcare professionals worldwide, with a focus on enhancing patient outcomes and infection control.